CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase
The DOI matches its Crossref record.
Abstract
T lymphocyte activation requires recognition of antigen by the antigen specific TCR as well as second co-stimulatory signals. This recognition event results in the activation of non-TCR linked protein tyrosine kinases (PTKs). The mechanism of co-stimulation of T cells is unknown except for the involvement of PTKs. The T cell surface molecule CD28 is effective in delivering co-stimulatory signals and prevents T cell anergy by inducing T cell proliferation in TCR stimulated T cells, primarily due to an increase in IL-2 production. The mechanism by which CD28 mediates this effect is currently unknown. Some conventional receptor molecules possess intrinsic tyrosine kinase and as a consequence of cross-linking or ligand binding, phosphorylate numerous tyrosines within their cytoplasmic tail, leading these tyrosines to become 'activated' and bind cytoplasmic effector molecules possessing Src homology 2 domains which specifically recognize phosphorylated tyrosines. One such cytoplasmic effector molecule is the phosphatidylinositol-3-phosphate kinase (PI3 kinase) which recognizes the motif phosphotyrosine-methione/valine-X-methionine (X being any amino acid) within the cytoplasmic tails of numerous receptor tyrosine kinases. As CD28 contains a copy of the PI3 kinase binding motif within its cytoplasmic tail, we investigated CD28 signaling and PI3 kinase activation. Here we demonstrate using the Jurkat cell line that CD28 becomes tyrosine phosphorylated following CD28 cross-linking and associates with PI3 kinase. Furthermore, a synthetic peptide representing the YM/VXM motif within the cytoplasmic tail of CD28 also interacts with PI3 kinase only when the tyrosine is phosphorylated.(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
Krummel, M. F., & Allison, J. P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.459 · Cited by 2,245
The CD28 Signaling Pathway Regulates Glucose Metabolism
Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., & Thompson, C. B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00323-0 · Cited by 1,475
Chemnitz, J. M., Parry, R. V., Nichols, K. E., June, C. H., & Riley, J. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.945 · Cited by 1,246
Control of peripheral T‐cell tolerance and autoimmunity via the CTLA‐4 and PD‐1 pathways
Fife, B. T., & Bluestone, J. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00662.x · Cited by 1,054
CD28 Costimulation: From Mechanism to Therapy
Esensten, J. H., Helou, Y. A., Chopra, G., Weiss, A., & Bluestone, J. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.020 · Cited by 937
CD28 and CTLA-4 coreceptor expression and signal transduction
Rudd, C. E., Taylor, A., & Schneider, H. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00770.x · Cited by 898
Rathmell, J. C., Heiden, M. G. V., Harris, M. H., Frauwirth, K. A., & Thompson, C. B. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00066-6 · Cited by 467
Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling.
Rudd, C. E., & Schneider, H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1131 · Cited by 392
T cell anergy and costimulation
Appleman, L. J., & Boussiotis, V. A. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00009.x · Cited by 305
Upshaw, J. L., Arneson, L. N., Schoon, R. A., Dick, C. J., Billadeau, D. D., & Leibson, P. J. (2006) · Nature Immunology · doi:10.1038/ni1325 · Cited by 300
An Enigmatic Tail of CD28 Signaling
Boomer, J. S., & Green, J. M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002436 · Cited by 283
“Interestingly CD28, CTLA-4, and ICOS share an YxxM motif (Rudd and Schneider 2003) a consensus binding site for the p85 subunit of the lipid kinase phosphatidyl-inositol 3-kinase (PI3K) (August and Dupont 1994; Pagès et al. 1994; Prasad et al. 1994).”
BackgroundA point mutation in CD28 distinguishes proliferative signals from survival signals.
Okkenhaug, K., Wu, L., Garza, K. M., La Rose, J., Khoo, W., Odermatt, B., Mak, T. W., Ohashi, P. S., & Rottapel, R. (2001) · Nature Immunology · doi:10.1038/86327 · Cited by 210
Tacke, M., Hanke, G., Hanke, T., & Hünig, T. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270136 · Cited by 163
CD28: a signalling perspective
WARD, S. G. (1996) · Biochemical Journal · doi:10.1042/bj3180361 · Cited by 149
Porciello, N., & Tuosto, L. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.02.004 · Cited by 61
Metadata
- Authors
- August, A., & Dupont, B.
- Venue
- International Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1994
- Volume
- 6
- Issue
- 5
- Pages
- 769-774
- ISSN
- 0953-8178 (ISSN-L)
- 1460-2377
- OpenAlex
- W2128042586
- Cited by
- 103
- References
- 0
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.